Proteome Sciences appoints Martin Diggle to the Board as Non-Executive Director

– UK – Proteome Sciences Plc is pleased to announce the appointment of Mr. Martin Diggle as a Non-Executive Director with immediate effect. 

Mr. Diggle, 52, has worked in finance for over 30 years. He was a director and partner of UBS/Brunswick in Russia until 2003, following which he joined Vulpes Investment Management, where he is currently a director and partner. He is an experienced specialist investor in life sciences and manages the Vulpes Life Sciences Fund, the registered holder of 33,400,217 ordinary shares in Proteome Sciences representing approximately15.6% of the Company’s ordinary share capital. 

Mr. Diggle is currently a Non-Executive Director of Oxford Biomedica plc and Chronos Therapeutics Limited. Mr Diggle holds an M.A in Philosophy, Politics and Economics from Oxford University.

- DisclaimerNews, data and statement included in this release are intended exclusively for general information purposes. Talent4Boards accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the adequacy or accuracy of the information. No data or statement in this release should be considered for decisions about securities referred. Product and brand names used in this release maybe trademarks or registered trademarks of their respective owners.

Comments are closed.